Heart failure in systemic lupus erythematosus

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease with diverse manifestations.
• Cardiovascular (CV) complications like atherosclerosis and myocardial infarction (MI) are known in SLE.
• The association between SLE and heart failure (HF) requires further investigation.

Purpose of the Study:

• To review the association between SLE and heart failure.
• To identify risk factors contributing to HF in SLE patients.
• To highlight the need for targeted interventions to improve CV outcomes.

Main Methods:

• Literature review of existing studies on SLE and cardiovascular disease.
• Analysis of traditional atherosclerotic risk factors in the context of SLE.
• Examination of SLE-specific factors and therapies contributing to HF risk.

Main Results:

• Traditional CV risk factors, SLE manifestations, and treatments independently and collectively elevate HF risk in SLE patients.
• Limited evidence currently exists specifically linking SLE to HF.
• Accelerated atherosclerosis and increased MI risk are recognized CV issues in SLE.

Conclusions:

• SLE patients face an increased risk of heart failure.
• A comprehensive understanding of contributing factors is crucial for risk stratification and management.
• Further large-scale intervention studies are necessary to address HF and improve CV health in SLE.